| Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-β1–dependent and–independent mechanisms S Mi, Z Li, HZ Yang, H Liu, JP Wang, YG Ma, XX Wang, HZ Liu, W Sun, ... The Journal of Immunology 187 (6), 3003-3014, 2011 | 410 | 2011 |
| TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription J Yu, W Sun, Z Wang, X Liang, F Hua, K Li, X Lv, X Zhang, Y Liu, J Yu, ... Nature communications 10 (1), 5720, 2019 | 161 | 2019 |
| TRB3 links insulin/IGF to tumour promotion by interacting with p62 and impeding autophagic/proteasomal degradations F Hua, K Li, JJ Yu, XX Lv, J Yan, XW Zhang, W Sun, H Lin, S Shang, ... Nature communications 6 (1), 7951, 2015 | 144 | 2015 |
| Loss of immunity‐supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll‐like receptor 2‐deficient mice H Lin, J Yan, Z Wang, F Hua, J Yu, W Sun, K Li, H Liu, H Yang, Q Lv, ... Hepatology 57 (1), 171-182, 2013 | 110 | 2013 |
| BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells JM Yu, W Sun, F Hua, J Xie, H Lin, DD Zhou, ZW Hu Cancer letters 365 (2), 190-200, 2015 | 103 | 2015 |
| Engineering a HER2-specific antibody–drug conjugate to increase lysosomal delivery and therapeutic efficacy JC Kang, W Sun, P Khare, M Karimi, X Wang, Y Shen, RJ Ober, ES Ward Nature biotechnology 37 (5), 523-526, 2019 | 74 | 2019 |
| A combined strategy improves the solubility of aggregation-prone single-chain variable fragment antibodies W Sun, J Xie, H Lin, S Mi, Z Li, F Hua, Z Hu Protein expression and purification 83 (1), 21-29, 2012 | 60 | 2012 |
| Targeting acute myeloid leukemia with a proapoptotic peptide conjugated to a toll‐like receptor 2‐mediated cell‐penetrating peptide K Li, XX Lv, F Hua, H Lin, W Sun, WB Cao, XM Fu, J Xie, JJ Yu, Z Li, H Liu, ... International journal of cancer 134 (3), 692-702, 2014 | 55 | 2014 |
| Selective Depletion of Antigen-Specific Antibodies for the Treatment of Demyelinating Disease W Sun, P Khare, X Wang, DK Challa, BM Greenberg, RJ Ober, ES Ward Molecular Therapy, 2020 | 22 | 2020 |
| Improvement in affinity and thermostability of a fully human antibody against interleukin-17A by yeast-display technology and CDR grafting W Sun, Z Yang, H Lin, M Liu, C Zhao, X Hou, Z Hu, B Cui Acta Pharmaceutica Sinica B 9 (5), 960-972, 2019 | 11 | 2019 |
| Optimizing the host bacteria to make a large naive phage antibody library in the recombination system W Sun, H Lin, F Hua, ZW Hu Yao xue xue bao= Acta Pharmaceutica Sinica 48 (1), 66-70, 2013 | 4 | 2013 |
| Endolysosomal targeting conjugates for improved delivery of cargo molecules to the endolysosomal compartment of target cells ESW Ober, RJ Ober, JC Kang, W Sun, R Li US Patent 11,690,919, 2023 | 3 | 2023 |
| Blocking extracellular HMGB1 activity protects against doxorubicin induced cardiac injury in mice YG Ma, XW Zhang, HY Bao, SS Yu, ZW Hu, W Sun Yao Xue Xue Bao= Acta Pharmaceutica Sinica 47 (11), 1489-1495, 2012 | 3 | 2012 |
| Selective depletion of radiolabeled HER2-specific antibody for contrast improvement during PET P Khare, W Sun, S Ramakrishnan, R Swiercz, G Hao, ST Lo, K Nham, ... MAbs 13 (1), 1976705, 2021 | 2 | 2021 |
| ENDOLYSOSOMAL TARGETING CONJUGATES FOR BETTER LOAD MOLECULES DISTRIBUTION TO ENDOLYSOSOMAL COMPARTMENT OF TARGET CELLS ESW OBER, RJ OBER, JCW KANG, W Sun, R Li | | 2021 |
| Making T cells functional: a new solution for the athymic BMT recipients W Sun, Z Hu Acta Pharmacologica Sinica 34 (2), 189-190, 2013 | | 2013 |
| Therapeutic antibody: new opportunity for immunity and inflammatory diseases W Sun, H Lin, F Hua, ZW Hu Yao xue xue bao= Acta Pharmaceutica Sinica 47 (10), 1306-1316, 2012 | | 2012 |
